It begins with an Instagram reel: an influencer touting the most potent weight-loss peptides. Two taps, and the feed is flooded with peptide-fuelled weight-loss journeys.
India plans to restrict the testing of vaccines and specialized biological products exclusively to government controlled laboratories to maintain quality standards, according to two government
Kiran Mazumdar-Shaw, Ex-ecutive Chairperson, Biocon Ltd, has flagged structural gaps in India’s biotech eco-system, warning that weak venture funding, regulatory bottlenecks, and the absence of
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessive daytime sleepiness, the company said
The US President Donald J Trump’s proclamation imposing 100% tariff on patented pharmaceuticals and their ingredients may have limited impact on the Indian pharma industry
India could soon get a lot thinner – at least in theory.On Friday the patent on semaglutide – the molecule behind Danish drugmaker Novo Nordisk’s
Hetero launches its generic semaglutide portfolio in international markets, enhancing access to advanced diabetes and obesity therapies. Hetero has launched its generic semaglutide portfolio in
Ultra-low dose of cancer meds works, reduces costs by 90%, finds Tata studyThe Parel-based premier cancer hospital found that giving one-tenth of the standard dosage
The eagerly anticipated semaglutide patent cliff in India has unleashed a strikingly varied pricing landscape. The intensity of the price decline is driven by the
New Delhi: Medicine prices in India may rise sharply amid a 30% surge in the cost of key raw materials or active pharma ingredients in
Copyright © 2025 Gubba Cold Storage Ltd, All rights reserved. Designed, Developed by TenJump